Navigation Links
Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis

Announces Positive Data in Animal Models of Ulcerative Colitis

NEW YORK, April 05, 2007 /PRNewswire-FirstCall/ -- Callisto Pharmaceuticals, Inc. , a developer of new drug treatments in the fight against cancer and other major health threats, announced today additional data confirming efficacy of Guanilib, a first-in-class compound currently being developed for the treatment of inflammatory bowel disease (IBD), in two different standard animal models of experimental colitis. Guanilib is an orally deliverable compound designed to mimic a naturally-occurring hormone called uroguanylin. The drug is currently in preclinical development and Callisto intends to move the drug into clinical trials in ulcerative colitis. Guanilib is a proprietary program that was developed in-house by Callisto scientists and the company owns 100% of the worldwide manufacturing and marketing rights.

The new animal data demonstrate that oral administration of Guanilib significantly reduces gastrointestinal (GI) inflammation, and confirm earlier evidence of down-regulation of interleukin-17 (IL-17), IL-23, and tumor necrosis factor (TNF), key cytokines that are known to be involved in etiology of IBD in humans. Guanilib treatment also improved stool consistency and removed intestinal blockage in treated animals.

"These are important findings and suggest a possible mechanism of action of Guanilib and implicate its therapeutic potential in GI inflammatory diseases such as IBD and IBS," said Dr. Kunwar Shailubhai, Senior Vice President, Discovery Research of Callisto, who is also the lead inventor of the issued patent covering therapeutic applications of Guanilib in GI inflammatory diseases and colon cancer.

Callisto believes that Guanilib is presently the best physiological ligand of guanylate cyclase receptor with the potential to provide a new way to treat gastrointestinal diseases, while exhibiting minimal side effects
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Callisto Pharmaceuticals Announces Publication of Research Article on Atiprimod Preclinical Studies in Mantle Cell Lymphoma
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:7/28/2015)... -- Edwards Lifesciences Corporation (NYSE: EW ), the global ... monitoring, today reported net income for the quarter ended ... share.  Adjusted net income on a non-GAAP basis was ... $0.88 per diluted share in the prior year period. ... $5.09 per diluted share, which included a $750 million ...
(Date:7/28/2015)... (NASDAQ: PMD ) today announced second quarter financial ... Company also announced a quarterly dividend of $0.15 per ... 7, 2015 to be paid on August 18, 2015.  ... quarterly dividend. The Company,s revenue for the ... $7.7 million for the quarter ended June 30, 2014, ...
(Date:7/28/2015)... 2015 A German Diabetes Center clinical study ... probiotic enriches human gut microbiota and modifies gut ... study involved daily administration of Nutraceutix,s L. reuteri ... patented BIO- tract ® delivery technology that ... their way to the intestinal tract. The ...
Breaking Medicine Technology:Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2
... Henry Schein, Inc. (Nasdaq: HSIC ), the ... practitioners, is joining with the American Dental Association (ADA) ... dental students and faculty with remote access to select ... and 2011 ADA Annual Session and World Marketplace Exhibition. ...
... Calif., Oct. 1 InterMune, Inc. (Nasdaq: ITMN ) ... President of InterMune, will present at the Fourth Annual JMP ... 2009 at 3:30 p.m. EDT. , To access ... interested parties may log on to the investor relations page ...
Cached Medicine Technology:Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 2Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 3Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii 4
(Date:7/28/2015)... ... July 29, 2015 , ... The insurance telematics or usage-based ... would allow insurers to access the on-board vehicle data and better understand customer behavior ... comes to sharing vehicle data. However times are changing and automakers realize that with ...
(Date:7/28/2015)... ... 28, 2015 , ... Santa Rosa’s The Press Democrat announced its annual report of the very ... and Dr. Heather Furnas took the top spot as the Best Cosmetic Surgeons in ... are proud to be bestowed such a prestigious title. , The Press Democrat ...
(Date:7/28/2015)... Port Richey, FL (PRWEB) , ... July 28, ... ... Brown University and The Miriam Hospital examines outcomes for inmates who continued methadone ... found the latter group was more likely to relapse to opiate use (1) ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Morristown Medical Center, ... Jersey, and one of the first five hospitals in the nation, to implant the ... patients on July 23, and all are in good condition. , The CoreValve® Evolut® ...
(Date:7/28/2015)... ... 28, 2015 , ... Healthline , a provider of intelligent health information ... consumers’ perspectives on digital health . The survey, which was conducted among 3,679 ... digital health, level of trust in the security of digital health tools, impact of ...
Breaking Medicine News(10 mins):Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5
... Steven Reinberg HealthDay Reporter , THURSDAY, April 28 ... cervical lesions should see their cancer risk drop to normal ... These women can then resume screening for cervical cancer ... "The question is how we should follow women who ...
... quality of life (HRQOL) for U.S. adults with arthritis is ... and mental health are affected by arthritis, which poses a ... diagnosed continues to climb. Details of this study are now ... published by Wiley-Blackwell on behalf of the American College of ...
... WEDNESDAY, April 27 (HealthDay News) -- Babies born prematurely need ... a matter of debate. A new report finds higher ... There are dangers of giving too much oxygen, severe eye ... well as lung and brain damage. But there are also ...
... specific form of vitamin E improved the most severe form ... study funded by the National Institutes of Health. Results appear ... the American Medical Association . A previous study found vitamin ... Nonalcoholic fatty liver disease (NAFLD) is the most common chronic ...
... WEDNESDAY, April 27 (HealthDay News) -- The growing number of ... more people are becoming caregivers, a responsibility that health experts ... caregivers can take various steps to protect their health, says ... Alzheimer Center in Houston. To keep stress in check, ...
... WEDNESDAY, April 27 (HealthDay News) -- Group visits to a ... The new study included 14 patients who received care through ... 13 patients who received usual care. The study participants had ... care group had 30-minute appointments with their doctor every three ...
Cached Medicine News:Health News:After Treatment for Precancerous Cervical Lesions, Risk Drops to Normal for Some 2Health News:After Treatment for Precancerous Cervical Lesions, Risk Drops to Normal for Some 3Health News:Adults with arthritis suffer with poorer health related quality of life 2Health News: Higher Oxygen Levels Improve Preemie Survival: Study 2Health News:Vitamin E helps diminish a type of fatty liver disease in children 2Health News:Vitamin E helps diminish a type of fatty liver disease in children 3Health News:Alzheimer's Caregivers Need Care, Too 2Health News:Group Visits With Doctor May Benefit Parkinson's Patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: